3251 - 3275 of 6422 Results
Title
Year
-
OPENTitle: Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease modelJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 25End Page: 25Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0062-4Best OA location URL: https://www.nature.com/articles/s41531-018-0062-4.pdfCitation Count: 95
-
OPENTitle: SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00468-xBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-021-00468-xCitation Count: 21
-
OPENTitle: CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorderJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-018-0129-5Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-018-0129-5Citation Count: 11
-
OPENTitle: Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage InferenceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-018-05892-0Best OA location URL: http://hdl.handle.net/10316/107788Citation Count: 434
-
OPENTitle: Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-33921-xBest OA location URL: https://www.nature.com/articles/s41598-018-33921-x.pdfCitation Count: 104
-
OPENTitle: Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaquesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 13Issue #: 9Start Page: e0202201End Page: e0202201Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0202201Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0202201&type=printableCitation Count: 16
-
OPENTitle: The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease targetJournal Name: BrainPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awy215Best OA location URL: https://academic.oup.com/brain/article-pdf/141/9/2721/25590456/awy215.pdfCitation Count: 42
-
OPENTitle: Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive DeclineJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.626974Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/85247Citation Count: 20
- Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research2021OPENTitle: Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical researchJournal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-021-05273-xBest OA location URL: https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-021-05273-xCitation Count: 33
-
OPENTitle: Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 4Start Page: 534End Page: 540Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13168Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/134137Citation Count: 24
-
OPENTitle: The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2019.00057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2019.00057/pdfCitation Count: 23
-
OPENTitle: Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathwaysJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0675-9Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0675-9Citation Count: 16
-
OPENTitle: Prioritizing Parkinson’s disease genes using population-scale transcriptomic dataJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-08912-9Best OA location URL: https://www.nature.com/articles/s41467-019-08912-9.pdfCitation Count: 159
-
OPENTitle: Computational medication regimen for Parkinson’s disease using reinforcement learningJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-88619-4Best OA location URL: https://www.nature.com/articles/s41598-021-88619-4.pdfCitation Count: 23
-
OPENTitle: Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-22399-3Best OA location URL: https://www.nature.com/articles/s41467-021-22399-3.pdfCitation Count: 69
-
OPENTitle: Novel Associations of BST1 and LAMP3 With REM Sleep Behavior DisorderJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000011464Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/136668Citation Count: 16
-
OPENTitle: Association of Mitochondrial DNA Genomic Variation With Risk of Pick DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000011649Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8055308Citation Count: 2
-
OPENTitle: In situ architecture of neuronal α-Synuclein inclusionsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-22108-0Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/123519Citation Count: 103
-
OPENTitle: Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesisJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 973End Page: 973Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-08858-yBest OA location URL: https://www.nature.com/articles/s41467-019-08858-y.pdfCitation Count: 313
-
OPENTitle: Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progressionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0079-3Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/90efcff0-e3bb-4445-b043-3b834c481f3fCitation Count: 61
-
OPENTitle: Defective homologous recombination DNA repair as therapeutic target in advanced chordomaJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-09633-9Best OA location URL: http://hdl.handle.net/11384/81716Citation Count: 83
-
OPENTitle: Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.645706Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.645706/pdfCitation Count: 21
-
OPENTitle: Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar DegenerationJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 2Start Page: 105End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000959Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8032415Citation Count: 6
-
OPENTitle: Cognitive and motor deficits in older adults with HIV infection: Comparison with normal ageing and Parkinson’s diseaseJournal Name: Journal of NeuropsychologyPublisher: WileyVol: 15Issue #: 2Start Page: 253End Page: 273Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnp.12227Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8026757Citation Count: 6
-
OPENTitle: Network Analysis of the CSF Proteome Characterizes Convergent Pathways of Cellular Dysfunction in ALSJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.642324Best OA location URL: https://doi.org/10.3389/fnins.2021.642324Citation Count: 8